Cargando…

Clinical Trial Enrollment, Ineligibility, and Reasons for Decline in Older vs Younger Patients With Cancer in the National Cancer Institute Community Oncology Research Program

This cross-sectional study assesses differences in clinical trial participation among older vs younger adults with cancer.

Detalles Bibliográficos
Autores principales:	Sedrak, Mina S., Ji, Jingran, Tiwari, Abhay, Mohile, Supriya G., Dale, William, Le-Rademacher, Jennifer G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552900/ https://www.ncbi.nlm.nih.gov/pubmed/36215074 http://dx.doi.org/10.1001/jamanetworkopen.2022.35714

Ejemplares similares

Exclusion of enrolled participants in randomised controlled trials: what to do with ineligible participants?
por: Rehman, Andrea M, et al.
Publicado: (2020)

Incorporation of text recognition into trial it systems to safeguard against enrolment of ineligible patients or inappropriate reporting of adverse events
por: Dennis, Martin, et al.
Publicado: (2013)

Disparities in patient enrollment on glioblastoma clinical trials
por: Liu, Yang, et al.
Publicado: (2020)

The Ineligibility of Antipyrin in Pneumonia
Publicado: (1886)

Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2023)

Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
por: Nieder, Carsten, et al.
Publicado: (2022)

Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya
por: Omosa-Manyonyi, Gloria S., et al.
Publicado: (2011)

In Reply to the Comment on “The Relationship Between Frailty and Emotional Health in Older Patients With Advanced Cancer”
por: Gilmore, Nikesha, et al.
Publicado: (2022)

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy
por: Jenkins, V, et al.
Publicado: (2000)

Daratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens: Efficacy in transplant‐ineligible untreated myeloma
por: Durie, Brian G. M., et al.
Publicado: (2020)

Reasons for Declining to Enroll in a Phase I and II HIV Vaccine Trial after Randomization among Eligible Volunteers in Dar es Salaam, Tanzania
por: Tarimo, Edith A. M., et al.
Publicado: (2011)

Removal of ineligible outcome cases reduces confounding
por: Walker, Alexander M, et al.
Publicado: (2018)

Tele-neuro-oncology: Current Practices and Future Directions
por: Wasilewski, Andrea, et al.
Publicado: (2022)

Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?
por: Fiscella, Kevin, et al.
Publicado: (2015)

Will colleges survive the storm of declining enrollments? A computational model
por: Pavlov, Oleg V., et al.
Publicado: (2020)

Five reasons COVID-19 is less severe in younger age-groups
por: Turke, Paul W
Publicado: (2020)

Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial
por: Ueda, Akira, et al.
Publicado: (2013)

Reason and reality—identifying barriers to patient enrolment for clinical trials in invasive candidiasis
por: Sprute, Rosanne, et al.
Publicado: (2022)

Physician Perceptions of the Use of Social Media for Recruitment of Patients in Cancer Clinical Trials
por: Sedrak, Mina S., et al.
Publicado: (2019)

Beyond abstraction: applying the brakes to runaway patent ineligibility
por: Burk, Dan L.
Publicado: (2016)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
por: Marcath, Lauren A., et al.
Publicado: (2018)

Assessment of Mortality Among Durable Left Ventricular Assist Device Recipients Ineligible for Clinical Trials
por: Brescia, Alexander A., et al.
Publicado: (2021)

A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults
por: Novotny, Paul J, et al.
Publicado: (2010)

Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer
por: Shafique, Michael R, et al.
Publicado: (2018)

Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical Analysis
por: Spector-Bagdady, Kayte, et al.
Publicado: (2022)

Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers
por: Graetz, Dylan E., et al.
Publicado: (2020)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2006)

Younger age is associated with greater early neurocognitive decline postcardiopulmonary bypass
por: Anderson, Kelsey, et al.
Publicado: (2020)

Oocyte vitrification for oncological and social reasons
por: Köroğlu, Nadiye, et al.
Publicado: (2023)

Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
por: Hyman, David M., et al.
Publicado: (2015)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2007)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2007)

Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials
por: Sedrak, Mina S., et al.
Publicado: (2020)

The short-term and oncologic outcomes of younger VS older colorectal cancer patients undergoing primary surgery: a propensity score matching analysis
por: Liu, Xiao-Yu, et al.
Publicado: (2022)

How I manage frontline transplant-ineligible multiple myeloma
por: Derudas, Daniele, et al.
Publicado: (2020)

Notification Strategy and Predictors of Outcome in Stroke Ineligible for Reperfusion Therapies
por: Mirolovics, Ágnes, et al.
Publicado: (2019)

Office-Based Laryngeal Biopsy in Patients Ineligible for General Anesthesia
por: Mozzanica, Francesco, et al.
Publicado: (2020)

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
por: Marin-Acevedo, Julian A., et al.
Publicado: (2023)

How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sbh9iqnq1ku6isqab82140avhb